Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Developmental Cell
|
October 4, 2005
Eomesodermin is a localized maternal determinant required for endoderm induction in zebrafish
Christopher R R Bjornson, Kevin J P Griffin, Gist H Farr, et al.
Development (Cambridge, England)
|
June 12, 2015
Wnt signaling and tbx16 form a bistable switch to commit bipotential progenitors to mesoderm
Cortney M Bouldin, Alyssa J Manning, Yu-Hsuan Peng, et al.
Cell Reports
|
March 25, 2015
Conversion of MyoD to a neurogenic factor: binding site specificity determines lineage
Abraham P Fong, Zizhen Yao, Jun Wen Zhong, et al.
Skeletal Muscle
|
October 16, 2020
A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy
Gist H Farr, Melanie Morris, Arianna Gomez, et al.
Elife
|
June 8, 2018
BMP and FGF signaling interact to pattern mesoderm by controlling basic helix-loop-helix transcription factor activity
Richard H Row, Amy Pegg, Brian A Kinney, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Epigenetic small molecule screening identifies a new HDACi compound for ameliorating Duchenne muscular dystrophy
Ke'ale W Louie, Eva H Hasegawa, Gist H Farr, et al.
Development (Cambridge, England)
|
September 26, 2003
GBP binds kinesin light chain and translocates during cortical rotation in Xenopus eggs
Carole Weaver, Gist H Farr, Weijun Pan, et al.
Plos Genetics
|
August 26, 2025
A systems genetics approach identifies roles for proteasome factors in heart development and congenital heart defects
Gist H Farr, Whitaker Reid, Eva H Hasegawa, et al.
Molecular Therapy. Nucleic Acids
|
September 8, 2025
Epigenetic small molecule screening identifies a new HDACi compound for ameliorating Duchenne muscular dystrophy
Ke'ale W Louie, Eva H Hasegawa, Gist H Farr, et al.
American Journal of Clinical Oncology
|
May 11, 2011
Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial
Steven R Alberts, Joel M Reid, Bruce W Morlan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Developmental Cell
|
October 4, 2005
Eomesodermin is a localized maternal determinant required for endoderm induction in zebrafish
Christopher R R Bjornson, Kevin J P Griffin, Gist H Farr, et al.
Development (Cambridge, England)
|
June 12, 2015
Wnt signaling and tbx16 form a bistable switch to commit bipotential progenitors to mesoderm
Cortney M Bouldin, Alyssa J Manning, Yu-Hsuan Peng, et al.
Cell Reports
|
March 25, 2015
Conversion of MyoD to a neurogenic factor: binding site specificity determines lineage
Abraham P Fong, Zizhen Yao, Jun Wen Zhong, et al.
Skeletal Muscle
|
October 16, 2020
A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy
Gist H Farr, Melanie Morris, Arianna Gomez, et al.
Elife
|
June 8, 2018
BMP and FGF signaling interact to pattern mesoderm by controlling basic helix-loop-helix transcription factor activity
Richard H Row, Amy Pegg, Brian A Kinney, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Epigenetic small molecule screening identifies a new HDACi compound for ameliorating Duchenne muscular dystrophy
Ke'ale W Louie, Eva H Hasegawa, Gist H Farr, et al.
Development (Cambridge, England)
|
September 26, 2003
GBP binds kinesin light chain and translocates during cortical rotation in Xenopus eggs
Carole Weaver, Gist H Farr, Weijun Pan, et al.
Plos Genetics
|
August 26, 2025
A systems genetics approach identifies roles for proteasome factors in heart development and congenital heart defects
Gist H Farr, Whitaker Reid, Eva H Hasegawa, et al.
Molecular Therapy. Nucleic Acids
|
September 8, 2025
Epigenetic small molecule screening identifies a new HDACi compound for ameliorating Duchenne muscular dystrophy
Ke'ale W Louie, Eva H Hasegawa, Gist H Farr, et al.
American Journal of Clinical Oncology
|
May 11, 2011
Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial
Steven R Alberts, Joel M Reid, Bruce W Morlan, et al.
Page
of 3